Eric R. Olson, Chief Scientific Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 1,753 shares at $11.72 ($21K) on 2020-07-07, disclosed to the SEC on 2020-07-07.
Scheduled sale ($21k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SYRS | SELL | 2021-07-01 | $6K | — | Filing → |
| SYRS | SELL | 2021-03-17 | $34K | — | Filing → |
| SYRS | SELL | 2020-08-19 | $205K | — | Filing → |